NAME OF PATIENT : MOHD ASHRAF AGE / SEX : 19/M

REFERRED BY DR. : MIRZA UBAIDULLAH LAB NO. : 10

DATE : 8-Aug-23
CBC(COMPLETE BLOOD COUNT)

TEST PATIENT VALUES UNITS REFERENCE RANGE

HAEMOGLOBIN : 14.20 gm/dl : 13 -- 18 MALE

: 11 -- 16 FEMALE
RBC COUNT : 4.19 Million/cmm : 4.0 - 5.5 MALE
: 4.0 - 5.0 FEMALE
P.C.V. : 41.20 % : 40 -- 54 MALE
: 37 -- 47 FEMALE
M.C.V. : 98.50 Cubic microns : 76 -- 96 M/F
M.C.H . : 33.80 pico gms : 27 -- 36 M/F
M.C.H.C. : 34.40 g/dl : 32 -- 36 M/F

PLATELETS : 3,15,000 lacs/Cu.MM : 1.5 -- 4.5 M/F

TOTAL WBC COUNT : 12,000 cells/ CuMM : 4,000 -- 11, 000 M/F

DIFFERENTIAL COUNT
NEUTROPHILS : 65 % : 40 -- 75 M/F
LYMPHOCYTES 30 % : 20 -- 45 M/F
EOSINOPHILS : 02 % : 01 -- 06 M/F
MONOCYTES : 03 % : 02 -- 08 M/F
BASOPHILS : 00 % : 00 -- 01 M/F
BAND FORMS : % : 00 -- 00 M/F

E.S.R. : 10 MM/hrs : 00 -- 20 MALE

(WESTERGREN METHOD) : 00 -- 30 FEMALE
RBC . MORPHOLOGY
HYPOCHROMIA : ABSENT POLYCHROMASIA : ABSENT
MICROCYTES : ABSENT SPHEROCYTES : ABSENT
ANISOCYTOSIS : ABSENT CRENATED RBCS : ABSENT
MACROCYTES : ABSENT STIPPLING : ABSENT
POIKILOCYTES : ABSENT TARGET CELLS : ABSENT
ELLIPTOCYTES : ABSENT TEAR DROP CELLS : ABSENT

REMARKS :

* IMPLIES RECHECKED.

PLEASE CORRELATE THE TEST RESULTS WITH THE CLINICAL FINDINGS.

CHECKED BY TECHNICAL STAFF DR.ISHTIYAQ ANSARI

MERAJ(CMLT DMLT BSMLT)
NAME OF PATIENT : MOHD ASHRAF AGE / SEX : 19/M

REFERRED BY DR. : MIRZA UBAIDULLAH LAB NO. : 10

DATE : 8-Aug-23
MALARIAL ANTIGEN TEST

TEST PATIENT'S VALUES UNITS REFERENCE RANGE

TECHNIQUE : J. MITRA MALARIA CARD TEST

RESULT : BAND C ( CONTROL )

BAND P ( PAN ) PRESENT

BAND F (P.F) ABSENT

TEST IS NEGATIVE FOR PAN AND P.F

* IMPLIES RECHECKED

REMARKS :

PLEASE CORRELATE THE TEST RESULTS WITH THE CLINICAL FINDINGS.

CHECKED BY TECHNICAL STAFF DR.ISHTIYAQ ANSARI

MERAJ(CMLT DMLT BSCMLT
NAME OF PATIENT : MOHD ASHRAF AGE / SEX : 19/M

REFERRED BY DR. : MIRZA UBAIDULLAH LAB NO. : 10

DATE : 8-Aug-23
WIDAL TEST

TEST PATIENT'S VALUES UNITS REFERENCE RANGE

S.TYPHI ANTIGENS RESULT TITRE

ANTIGEN "O" AGGLUTINATION 1 : 160

ANTIGEN "H" AGGLUTINATION 1 : 80

S.PARATYPHI ANTIGENS

ANTIGEN "AH" NO AGGLUTINATION NIL

ANTIGEN "BH" NO AGGLUTINATION NIL

RESULT : POSITIVE

METHOD : SLIDE AGGLUTINATION.

AGGLUTININ TITRE OF GREATER THAN I : 80 IS CONSIDERED TO BE SIGNIFICANT

AND USUALLY SUGGESTIVE OF INFECTION.

A SINGLE POSITIVE RESPONSE HAS LESS SIGNIFICANCE THAN A RISING AGGLUTININ

TITRE.

FALSE NEGATIVE RESULT MAY BE SEEN IN FIRST WEEK, AFTER THE FOURTH WEEK,
OR AFTER ANTIBIOTIC THERAPY.

ANAMNESTIC REACTION: PERSONS WHO HAVE HAD PRIOR INFECTION OR

IMMUNISATION WITH T.A.B. VACCINE MAY SHOW A FALSE POSITIVE TEST DURING
AN UNRELATED INFECTION.

REMARKS :

* IMPLIES RECHECKED.

PLEASE CORRELATE THE TEST RESULTS WITH THE CLINICAL FINDINGS.

CHECKED BY TECHNICAL STAFF DR.ISHTIYAQ ANSARI

MERAJ(CMLT DMLT BSCMLT)
NAME OF PATIENT : MOHD ASHRAF AGE / SEX : 19/M

REFERRED BY DR. : MIRZA UBAIDULLAH LAB NO. : 10

DATE : 8-Aug-23
LIVER PROFILE TEST ( L.F.T. )

TEST PATIENT'S VALUES UNITS REFERENCE RANGE

SERUM S.G.O.T : 22.00 IU/L 06 -- 38 IU/L

SERUM S.G.P.T. : IU/L 00 -- 35 IU/L

ALK - PHOS : - U/L ADULTS :98 -- 279 U/L

CHILDREN :UPTO 645 U/L

SERUM BILIRUBIN TOTAL : MG/DL UPTO 1.20 MG/DL

SERUM BILIRUBIN DIRECT : MG/DL UPTO 0.25 MG/DL

SERUM BILIRUBIN INDIRECT: MG/DL UPTO 1.00 MG/DL

SERUM TOTAL PROTEIN : - G/DL 6.4 -- 8.4 G/DL

SERUM ALBUMIN : - G/DL 3.5 -- 5.0 G/DL

SERUM GLOBULIN : - G/DL 1.6 -- 2.0 G/DL

SERUM ALB/GLO RATIO : - G/DL 1.5 -- 2.5 G/DL

REMARKS : -

* IMPLIES RECHECKED

PLEASE CORRELATE THE TEST RESULTS WITH THE CLINICAL FINDINGS.

CHECKED BY TECHNICAL STAFF DR.ISHTIYAQ ANSARI

MERAJ(CMLT DMLT BSCMLT)
NAME OF PATIENT : MOHD ASHRAF AGE / SEX : 19/M

REFERRED BY DR. : DR. MIRZA UBAIDULLAH LAB NO. :

DATE : 8-Aug-23
C- REACTIVE PROTEIN (C.R.P.)

TEST PATIENT'S VALUES UNITS REFERENCE RANGE

C.R.P. TITRE : 1.60 MG/L UPTO 6.00

RESULT : NEGATIVE NEGATIVE

METHOD : LATEX TURBIDIMETRY

COMMENTS : CRP APPEARS IN THE SERUM OF INDIVIDUALS IN RESPONSE TO VARIOUS

INFLAMMATORY CONDITIONS AND TISSUE NECROSIS AND DISAPPEARS AS
THE CAUSATIVE CONDITIONS SUBSIDE.
IT IS ROUTINELY FOUND IN CASES OF BACTERIAL INFECTION, ACTIVE
RHEUMATIC FEVER, MANY MALIGNANT DISEASES AND IS OFTEN SEEN IN
ASSOCIATION WITH RHEUMATOID ARTHRITIS, VIRAL INFECTIONS AND T.B.
CRP HAS BEEN DETECTED IN PATIENTS AFTER BLOOD TRANSFUSIONS,
SURGICAL OPERATIONS, PATIENTS WITH BURNS, PEMPHIGUS VULGARIS &
OTHER BULLOUS LESIONS.
ELEVATION OF CRP LEVELS ABOVE NORMAL RANGE INDICATES TISSUE
DAMAGE, INFLAMMATION AND BOTH WITH GREATER RELIABILITY.
REGULAR MONITORING OF CRP LEVELS IS OFTEN USED AS A MEANS OF
ASSESSING DISEASE ACTIVITY AND OF GUIDING THERAPY.
CRP DETERMINATION IS CONSIDERED TO BE OF GREATER PRACTICAL
SIGNIFICANCE THAN ANY OTHER INDICATOR OF INFLAMMATORY DISEASE.
SINCE CRP PRODUCTION IS A NONSPECIFIC RESPONSE TO TISSUE INJURY.,
IT IS RECOMMENDED THAT THE RESULTS ARE CLINICALLY CORRELATED.

* IMPLIES RECHECKED

REMARKS :

PLEASE CORRELATE THE TEST RESULTS WITH THE CLINICAL FINDINGS.

CHECKED BY TECHNICAL STAFF DR.ISHTIYAQ ANSRI

MERAJ(CMLT DMLT BSCMLT)